JP Stock MarketDetailed Quotes

4588 Oncolys BioPharma

Watchlist

652
-3-0.46%

20min DelayTrading May 29 11:30 JST

13.61BMarket Cap-5986P/E (Static)

Oncolys BioPharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Total revenue

-93.54%63.04M

-87.97%28.04M

-81.88%35M

51.94%976.18M

-40.87%191.67M

186.11%358.36M

78.61%233.03M

Cost of revenue

-94.91%32.43M

-50.59%32.43M

43.73%637.7M

-44.58%163.34M

201.47%287.66M

569.22%121.06M

Gross profit

-90.96%30.6M

-74.96%28.04M

-97.99%2.57M

70.26%338.49M

-3.70%28.34M

137.01%70.7M

-0.36%111.97M

Operating expense

15.46%378.87M

27.06%1.96B

109.49%618.95M

17.43%410.05M

56.28%603.45M

-35.94%328.15M

-6.68%1.54B

-43.22%295.46M

-2.97%349.18M

-2.62%386.12M

Operating profit

-16.37%-378.87M

-60.23%-1.93B

-131.71%-618.95M

-47.24%-410.05M

-109.89%-575.41M

15.38%-325.58M

17.19%-1.2B

45.59%-267.13M

15.62%-278.48M

3.52%-274.15M

Net non-operating interest income (expenses)

-337.39%-3.09M

-311.25%-13.93M

-398.88%-4.01M

-862.20%-8.68M

42.46%-542K

4.72%-706K

78.48%-3.39M

46.86%-803K

6.82%-902K

17.51%-942K

Non-operating interest income

247.65%518K

151.28%1.48M

262.79%468K

172.41%474K

193.13%384K

-2.61%149K

18.83%587K

15.18%129K

20.83%174K

22.43%131K

Non-operating interest expense

33.33%1.14M

-8.69%3.6M

-11.70%823K

-7.25%998K

-13.70%926K

-1.04%855K

-5.37%3.95M

-4.70%932K

-0.55%1.08M

-8.84%1.07M

Total other finance cost

--2.47M

39,253.33%11.81M

--3.65M

----

-99.75%30K

--0

Net investment income

484.84%18.67M

-55.94%27.6M

46.47%-20.08M

-20.12%12.62M

-29.14%31.86M

-91.89%3.19M

67.62%62.64M

-524.70%-37.51M

292.43%15.8M

3,884.85%44.96M

Gain(Loss) on financial instruments designated as cash flow hedges

Gain(Loss) on derecognition of available-for-sale financial assets

Income from associates and other participating interests

Special income (charges)

-227.99%-21.76M

-397.34%-21.9M

136K

185.68%17M

77.81%-4.4M

21.41M

Less:Other special charges

----

99.36%-136K

--0

---136K

---21.41M

--0

----

Less:Write off

----

397.34%21.9M

----

-77.81%4.4M

----

Other non-operating income (expenses)

114.09%2.5M

868.52%2.76M

73.88%-17.76M

92.28%-3.12M

59.53%-359K

16.69%-10.76M

Income before tax

-12.49%-363.29M

-68.90%-1.94B

-112.47%-664.93M

-52.82%-403.34M

-125.98%-544.35M

1.60%-322.96M

28.90%-1.15B

50.70%-312.96M

19.50%-263.94M

19.54%-240.89M

Income tax

27.72%940K

-0.20%2.93M

0.00%733K

-0.27%736K

-0.28%721K

-0.27%736K

-21.29%2.93M

-21.86%733K

-21.74%738K

-19.93%723K

Net income

-12.52%-364.23M

-68.72%-1.94B

-112.20%-665.66M

-52.67%-404.08M

-125.60%-545.07M

1.60%-323.69M

28.88%-1.15B

50.66%-313.69M

19.51%-264.68M

19.54%-241.61M

Net income continuous operations

-12.52%-364.23M

-68.72%-1.94B

-112.20%-665.66M

-52.67%-404.08M

-125.60%-545.07M

1.60%-323.69M

28.88%-1.15B

50.66%-313.69M

19.51%-264.68M

19.54%-241.61M

Noncontrolling interests

Net income attributable to the company

-12.52%-364.23M

-68.72%-1.94B

-112.20%-665.66M

-52.67%-404.08M

-125.60%-545.07M

1.60%-323.69M

28.88%-1.15B

50.66%-313.69M

19.51%-264.68M

19.54%-241.61M

Preferred stock dividends

Other under preferred stock dividend

Net income attributable to common stockholders

-12.52%-364.23M

-68.72%-1.94B

-112.20%-665.66M

-52.67%-404.08M

-125.60%-545.07M

1.60%-323.69M

28.88%-1.15B

50.66%-313.69M

19.51%-264.68M

19.54%-241.61M

Gross dividend payment

Basic earnings per share

2.41%-18.24

-64.26%-108.92

-97.52%-35.77

-50.46%-22.99

-125.75%-31.47

1.53%-18.69

30.57%-66.31

51.16%-18.11

19.45%-15.28

18.43%-13.94

Diluted earnings per share

2.41%-18.24

-64.26%-108.92

-97.52%-35.77

-50.46%-22.99

-125.75%-31.47

1.53%-18.69

30.57%-66.31

51.16%-18.11

19.48%-15.28

19.57%-13.94

Dividend per share

Currency Unit

JPY

Accounting Standards

NonUS-GAAP

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Total revenue	0	-93.54%63.04M	0	0	-87.97%28.04M	-81.88%35M	51.94%976.18M	-40.87%191.67M	186.11%358.36M	78.61%233.03M
Cost of revenue	0	-94.91%32.43M	0	0	0	-50.59%32.43M	43.73%637.7M	-44.58%163.34M	201.47%287.66M	569.22%121.06M
Gross profit	0	-90.96%30.6M	0	0	-74.96%28.04M	-97.99%2.57M	70.26%338.49M	-3.70%28.34M	137.01%70.7M	-0.36%111.97M
Operating expense	15.46%378.87M	27.06%1.96B	109.49%618.95M	17.43%410.05M	56.28%603.45M	-35.94%328.15M	-6.68%1.54B	-43.22%295.46M	-2.97%349.18M	-2.62%386.12M
Operating profit	-16.37%-378.87M	-60.23%-1.93B	-131.71%-618.95M	-47.24%-410.05M	-109.89%-575.41M	15.38%-325.58M	17.19%-1.2B	45.59%-267.13M	15.62%-278.48M	3.52%-274.15M
Net non-operating interest income (expenses)	-337.39%-3.09M	-311.25%-13.93M	-398.88%-4.01M	-862.20%-8.68M	42.46%-542K	4.72%-706K	78.48%-3.39M	46.86%-803K	6.82%-902K	17.51%-942K
Non-operating interest income	247.65%518K	151.28%1.48M	262.79%468K	172.41%474K	193.13%384K	-2.61%149K	18.83%587K	15.18%129K	20.83%174K	22.43%131K
Non-operating interest expense	33.33%1.14M	-8.69%3.6M	-11.70%823K	-7.25%998K	-13.70%926K	-1.04%855K	-5.37%3.95M	-4.70%932K	-0.55%1.08M	-8.84%1.07M
Total other finance cost	--2.47M	39,253.33%11.81M	--3.65M	----	----	----	-99.75%30K	--0	--0	--0
Net investment income	484.84%18.67M	-55.94%27.6M	46.47%-20.08M	-20.12%12.62M	-29.14%31.86M	-91.89%3.19M	67.62%62.64M	-524.70%-37.51M	292.43%15.8M	3,884.85%44.96M
Gain(Loss) on financial instruments designated as cash flow hedges
Gain(Loss) on derecognition of available-for-sale financial assets
Income from associates and other participating interests
Special income (charges)	0	-227.99%-21.76M	-397.34%-21.9M	0	0	136K	185.68%17M	77.81%-4.4M	0	21.41M
Less:Other special charges	----	99.36%-136K	--0	--0	--0	---136K	---21.41M	--0	--0	----
Less:Write off	----	397.34%21.9M	----	----	----	----	-77.81%4.4M	----	----	----
Other non-operating income (expenses)		114.09%2.5M	0	868.52%2.76M			73.88%-17.76M	92.28%-3.12M	59.53%-359K	16.69%-10.76M
Income before tax	-12.49%-363.29M	-68.90%-1.94B	-112.47%-664.93M	-52.82%-403.34M	-125.98%-544.35M	1.60%-322.96M	28.90%-1.15B	50.70%-312.96M	19.50%-263.94M	19.54%-240.89M
Income tax	27.72%940K	-0.20%2.93M	0.00%733K	-0.27%736K	-0.28%721K	-0.27%736K	-21.29%2.93M	-21.86%733K	-21.74%738K	-19.93%723K
Net income	-12.52%-364.23M	-68.72%-1.94B	-112.20%-665.66M	-52.67%-404.08M	-125.60%-545.07M	1.60%-323.69M	28.88%-1.15B	50.66%-313.69M	19.51%-264.68M	19.54%-241.61M
Net income continuous operations	-12.52%-364.23M	-68.72%-1.94B	-112.20%-665.66M	-52.67%-404.08M	-125.60%-545.07M	1.60%-323.69M	28.88%-1.15B	50.66%-313.69M	19.51%-264.68M	19.54%-241.61M
Noncontrolling interests
Net income attributable to the company	-12.52%-364.23M	-68.72%-1.94B	-112.20%-665.66M	-52.67%-404.08M	-125.60%-545.07M	1.60%-323.69M	28.88%-1.15B	50.66%-313.69M	19.51%-264.68M	19.54%-241.61M
Preferred stock dividends
Other under preferred stock dividend	0	0	0	0	0	0	0	0	0	0
Net income attributable to common stockholders	-12.52%-364.23M	-68.72%-1.94B	-112.20%-665.66M	-52.67%-404.08M	-125.60%-545.07M	1.60%-323.69M	28.88%-1.15B	50.66%-313.69M	19.51%-264.68M	19.54%-241.61M
Gross dividend payment
Basic earnings per share	2.41%-18.24	-64.26%-108.92	-97.52%-35.77	-50.46%-22.99	-125.75%-31.47	1.53%-18.69	30.57%-66.31	51.16%-18.11	19.45%-15.28	18.43%-13.94
Diluted earnings per share	2.41%-18.24	-64.26%-108.92	-97.52%-35.77	-50.46%-22.99	-125.75%-31.47	1.53%-18.69	30.57%-66.31	51.16%-18.11	19.48%-15.28	19.57%-13.94
Dividend per share
Currency Unit	JPY	JPY	JPY	JPY	JPY	JPY	JPY	JPY	JPY	JPY
Accounting Standards	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall